Free Trial
→ Elon Takes Aim at Social Security (From Altimetry) (Ad) Free NEUP Stock Alerts

Neuphoria Therapeutics Inc. - Common Stock (NEUP) SEC Filings & 10K Form

Neuphoria Therapeutics Inc. - Common Stock logo
$4.88 -0.17 (-3.37%)
As of 02/21/2025 04:00 PM Eastern
Compare

Recent Neuphoria Therapeutics Inc. - Common Stock SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
4:06 PM		ARMISTICE CAPITAL, LLC (Filed by)
Neuphoria Therapeutics Inc. (Subject)
Neuphoria Therapeutics Inc. (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:58 AM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/12/2025
5:45 AM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 424B5
02/04/2025
5:15 AM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 424B5
01/29/2025
11:15 PM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form EFFECT
01/28/2025
11:16 AM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/27/2025
8:23 AM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/14/2025
4:28 PM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2025
11:15 PM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form EFFECT
01/07/2025
5:18 AM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form S-3/A
12/29/2024
11:15 PM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form EFFECT
12/29/2024
11:15 PM		Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form EFFECT
12/23/2024
4:14 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:56 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 15-12G
12/23/2024
4:02 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form POS AM
12/23/2024
4:03 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form POS AM
12/16/2024
3:46 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
4:02 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
3:01 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:41 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
2:25 PM		ARMISTICE CAPITAL, LLC (Filed by)
BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Form SC 13G
11/14/2024
8:03 AM		BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Lynx1 Capital Management LP (Filed by)
Form SC 13G/A
11/13/2024
3:55 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form DEFA14A
10/10/2024
4:00 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:47 AM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form PRE 14A
10/07/2024
5:10 PM		Apeiron Investment Group Ltd. (Filed by)
BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics Inc. - Common Stock (Subject)
Form SC 13D/A
09/30/2024
5:38 AM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/16/2024
5:30 AM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
6:18 PM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Davies Peter Miles Winston (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:16 AM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Cunningham Timothy M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:10 AM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Papapetropoulos Spyros (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:11 AM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Weaver Aaron Ngoc Dung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:13 AM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Fisher Alan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:14 AM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Wilson David Ian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:15 AM		BIONOMICS LIMITED/FI (Issuer)
BIONOMICS LIMITED/FI (Issuer)
Neuphoria Therapeutics Inc. - Common Stock (Issuer)
Ryan Jane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/26/2024
11:15 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form EFFECT
06/26/2024
4:14 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 424B3
06/18/2024
6:05 AM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/03/2024
4:18 PM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2024
5:06 AM		BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics Inc. - Common Stock (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NEUP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...
Porter & Company | Sponsored